Kinesin and dynein motors transport intracellular cargos bidirectionally by pulling them in opposite directions along microtubules, through a process frequently described as a 'tug of war' 1 . While kinesin produces 6 pN of force, mammalian dynein was found to be a surprisingly weak motor (0.5-1.5 pN) in vitro, suggesting that many dyneins are required to counteract the pull of a single kinesin 2 . Mammalian dynein's association with dynactin and Bicaudal-D2 (BICD2) activates its processive motility 3-6 , but it was unknown how this affects dynein's force output. Here, we show that formation of the dynein-dynactin-BICD2 (DDB) complex increases human dynein's force production to 4.3 pN. An in vitro tug-of-war assay revealed that a single DDB successfully resists a single kinesin. Contrary to previous reports, the clustering of many dyneins is not required to win the tug of war. Our work reveals the key role of dynactin and a cargo adaptor protein in shifting the balance of forces between dynein and kinesin motors during intracellular transport.
Cytoplasmic dynein ('dynein' hereafter) is a minus-end-directed microtubule motor responsible for cargo trafficking, organelle positioning, and organization of the mitotic spindle in eukaryotic cells 7 . The core of the dynein complex comprises a homodimer of two massive heavy chains, each containing a AAA+ motor ring, a microtubule-binding domain separated from the ring by a ∼15 nm coiled-coil stalk, and a flexible cargo-binding tail that also serves as the dimerization domain and the binding site for dynein light and intermediate chains 8, 9 . Previous studies on mammalian dynein revealed a striking mismatch between the motility of individual motors in vitro and their apparent in vivo functions. Despite high retrograde transport velocities observed in live cells 10 , single purified mammalian dyneins exhibited diffusive motility or short processive runs in vitro 9, 11, 12 and were found to stall at forces of 0.5-1.5 pN (refs 9,13-17) , significantly weaker than the 6 pN force production of plus-end-directed kinesin-1 motors 18 . It remained unclear how dynein generates the large forces required for its cellular roles. It has been proposed that multiple (4-7) dynein motors need to be engaged in transport per kinesin-1 to balance forces during tug of war 2 , and that the spatial organization of dyneins on the surface of the cargo serves a fundamental regulatory role 19 . However, due to dynein's large size, it may not be sterically feasible for multiple dynein motors to interact with a microtubule when transporting small cargos 1 . Furthermore, measured dynein to kinesin ratios (∼1.5:1) on mouse axonal membranous vesicles 20 are inconsistent with the ∼5:1 coupling predicted by force-based models.
Recent studies with recombinant human dynein have begun to explore the mechanism of its motility. Both velocity and processivity of dynein are dramatically increased by the addition of dynactin, a multiprotein complex that associates with dynein in vivo, together with the amino terminus of the cargo activator Bicaudal-D2 (BICD2N), which increases the affinity of dynactin for dynein [3] [4] [5] [6] (Fig. 1a-d ). In singlemolecule motility experiments on sea urchin axonemes, we observed that human dynein is poorly recruited to axonemes (0.19 fluorescent spots µm −1 min −1 at 1 nM motor) and only 16% of dynein spots exhibited slow (79 ± 11 nm s −1 , mean ± s.e.m.), processive motility (Supplementary Video 1 and Supplementary Fig. 1a ). The addition of dynactin and SNAPf-tagged BICD2N (hereafter BICD2N) at a 1:5:2 dynein/dynactin/BICD2N molar ratio increased the recruitment of dynein to 0.66 spots µm −1 min −1 at 1 nM motor, with a substantially higher percentage (52%) of processively moving spots (Supplementary Video 2 and Supplementary Fig. 1b ), resulting in a tenfold increase in the number of walking molecules. These results are consistent with the enhancement of dynein recruitment and processivity in the presence of dynactin and BICD2N.
The autoinhibition of dynein may be mediated by a large-scale rearrangement of the tail domain, as is the case for some members of myosin 21 and kinesin 22 families, or by the back-to-back stacking of the motor domains 9 . The tail-inactivation hypothesis, wherein the tail folds over onto the motor domains and inhibits their activity, has previously been rejected because attaching quantum dots (QDs) to human dynein's tail did not enhance its motility 9 . However, QDs are similar in size (∼20 nm in diameter) to dynein itself, and may be too small to release inhibition. To test this possibility, we attached a range of artificial cargos to dynein's tail and tested its motility in vitro. In agreement with the findings of ref. 9, binding a QD to dynein's tail did not increase dynein's velocity as the QD-labelled dynein walked at 49 ± 11 nm s −1 and the majority of QDs did not exhibit any processive motility along axonemes (n = 19 walking QDs out of 319 observed, Fig. 1e ). However, attachment of larger cargos to dynein's tail resulted in fast processive runs. Single dynein motors carried 200-nm-diameter beads at 200 ± 23 nm s −1 in unloaded conditions ( Fig. 1f and Supplementary Video 3) and 860-nm-diameter beads at 257 ± 26 nm s −1 under 0.4 pN constant hindering force 23 (Fig. 1g ), which was applied to allow for reliable detection of dynein unbinding from the microtubule.
This ∼4-fold increase in dynein's velocity indicates that release of dynein from the autoinhibited state can be partially stimulated by attachment of a large cargo to the tail domain, consistent with reports of bead motility driven by nonspecifically adsorbed mammalian dyneins 15, 23 . Importantly, the DDB complex moves ∼2-fold faster than dyneins carrying a large bead ( Fig. 1h ). Therefore, dynactin and BICD2 binding probably leads to additional conformational changes of the heavy chains, such as alignment of the motor domains 24 and reorientation of the carboxy terminus 25 .
To test whether formation of the DDB complex enhances dynein's work output, we measured the force generation of dynein, dynein-dynactin and the DDB complex using an optical trap. We sparsely attached recombinant human dynein motors containing an N-terminal GFP to micrometre-sized polystyrene beads coated with anti-GFP antibody ( Fig. 2a ). With the trap held in a fixed position, the minus-end-directed motility of beads driven by individual dynein motors stalled at 2.04 ± 0.02 pN (mean ± s.e.m.) resistive forces, slightly higher than previously reported stall forces of human dynein. Addition of dynactin to human dynein at a fivefold molar excess caused only a modest (P = 0.0025, Welch's t-test) increase in stall force to 2.48 ± 0.06 pN ( Fig. 2b ), consistent with previous findings that dynactin alone has little effect on dynein motility 3, 4 . We next assembled the DDB complex at a 1:5:2 molar ratio of dynein/dynactin/BICD2N. Single-molecule motility assays showed robust processive motility at this ratio ( Fig. 1b ). With all three components present, stall forces exhibited a bimodal distribution with a lower peak at 2.1 ± 0.3 pN, comprising 34% of all motors, and a higher peak at 4.4 ± 0.5 pN, comprising 70% of the 195 observed motors ( Fig. 2c and Supplementary Fig. 2) . A third peak is not warranted in the fit ( Fig. 2c and Supplementary Fig. 2 ). It is likely that the lower peak at 2.1 pN corresponds to incomplete complex formation because in single-molecule motility assays, only 52% of GFP-tagged dynein motors move processively following addition of dynactin and BICD2N. The stall forces near 4.3 pN appear only when all three components are present, suggesting that they correspond to the force output of DDB. To confirm this, we measured the stall force of DDB by attaching the bead directly to the N-terminal 400 residues of BICD2 via a C-terminal GFP tag (BICD2N-GFP), ensuring that any observed motility is driven by DDB rather than dynein alone. The beads stalled at 4.3 ± 0.2 pN ( Fig. 2d ), similar to the 4.3 pN peak observed in Fig. 2c . A peak in stall events near 2.1 pN was not observed. Thus, we concluded that DDB complexes produce forces above 4 pN. To make a direct comparison with yeast cytoplasmic dynein, whose motility mechanism has been studied in detail [26] [27] [28] [29] , we independently measured the stall force of full-length yeast dynein to be 3.6 ± 0.2 pN ( Supplementary Fig. 3 ). Therefore, force production of mammalian dynein is similar to yeast cytoplasmic dynein 28 and less than human kinesin-1 18 (5.8 ± 0.1 pN; Fig. 2e ).
We sought to rule out the possibility that multiple dyneins aggregate in fluorescence or trapping assays. First, we counted the number of photobleaching steps of microtubule-bound dynein dimers tagged with a single GFP on each monomer. Ninety-five per cent of the GFP spots bleached in either one or two steps in the presence and absence of dynactin and BICD2N ( Fig. 3a-c ), suggesting that they correspond to a single dynein dimer. In the trapping experiments, to prevent the possibility of dynactin-and BICD2N-induced aggregation of dynein on the surface of beads, we pre-bound dynein sparsely to beads, removed the free motors, and then added dynactin and BICD2N (Fig. 3d ). Under these conditions, dynein still produced high stall forces, 4.0 ± 0.2 pN, similar to the case in which all three components were mixed before bead binding ( Fig. 3e) . Therefore, the measured increase in stall force of DDB is not an artefact of aggregation, but rather caused by the binding of dynactin and BICD2N to individual dynein motors. Finally, to ensure that trapped beads are driven by a single motor, we quantified the fraction of motile beads as a function of dynein concentration 30 (Fig. 3f) . The data fitted well to the model that each bead is carried by one or more motors and did not fit well to the model that a minimum of two motors is required to carry a bead.
All trapping experiments in this work were performed at 20 pM dynein at which >97% of all beads were driven by single motors.
To investigate the effect of dynein activation by its adaptor proteins on the motor's ability to transport cargo in competition with motors of opposing polarity, we established an in vitro tug-of-war assay 31, 32 allowing us to pit one dynein against one human kinesin-1. A dynein construct with an N-terminal SNAPf tag was first labelled substoichiometrically with a 74-nucleotide-long single-stranded DNA, and then with an excess of Alexa647 at its tail. This labelling strategy ensured that most dynein dimers were labelled with either one DNA molecule and one Alexa647 fluorophore, or two Alexa647 fluorophores. A similar strategy was used to label kinesin with a complementary DNA and a tetramethylrhodamine (TMR) at its tail using HaloTag (see Methods and Fig. 4a-c) . The labelled motors were linked to each other through DNA hybridization, and assayed for motility on microtubules polymerized from pig brain tubulin.
Simultaneous imaging of TMR-kinesin and Alexa647-dynein on microtubules revealed co-localization and correlated movement of dynein-kinesin complexes. By relying on sub-stoichiometric DNA labelling, we ensured that any observed co-localizers were comprised of one dynein and one kinesin motor. In the absence of dynactin and BICD2N, the velocities of co-localizers were nearly the same as those of kinesins alone (Fig. 4d,e and Supplementary Video 4) , revealing that dynein on its own is unable to resist kinesin's pull.
However, the behaviour of the co-localizers was markedly different following the addition of dynactin and BICD2N. The median velocity of DDB-kinesin co-localizers (26 nm s −1 ) was reduced over 20-fold compared with that of dynein-kinesin (464 nm s −1 ) towards the microtubule plus end. Furthermore, 22% of DDB-kinesin colocalizers walked towards the microtubule minus end (Fig. 4f,g and Supplementary Fig. 4 and Supplementary Video 5), which was not observed in the absence of dynactin and BICD2N. The velocity distribution of the co-localizers is distinct from those of both DDB alone and kinesin alone, indicating that both motors are contributing to the overall motility rather than one being passively carried by the winning motor. Interestingly, we did not observe frequent reversals of a DDB-kinesin co-localizer's motility. This agrees with the absence of reversals in the artificial linking of multiple yeast dyneins to multiple human kinesins 31 . Reversals of cargo motility observed in vivo 1 may result from the regulatory factors on the cargo that modulate motor activity, such as JIP1 33 , or transient association of key regulatory proteins such as dynactin and BICD2 in cells 1 .
Next, we tested whether the dramatic slowing down and reversal of DDB motility can be explained by a purely mechanical response to kinesin's pulling force towards the plus end. Operating an optical trap in a force-feedback mode, we pulled single DDB complexes towards the plus end with a force of 6 pN, corresponding to the reported stall force of kinesin-1 (Fig. 2e) 18 . Under this condition, the median velocity of DDB was 10 nm s −1 towards the plus end, with 29% of the motors walking towards the minus end (Fig. 4g,h) . These values are remarkably similar to the velocities of DDB-kinesin co-localizers, which is consistent with the predictions of the tug-of-war model.
Our results demonstrated that mammalian dynein complexes are strong motors capable of transporting cargos towards the microtubule minus end against large resistive forces. Contrary to the earlier suggestion that 4-7 dyneins are needed to counteract the force production of a single kinesin-1 34 , the activation of human dynein by dynactin and BICD2N allows it to dramatically slow down and sometimes defeat kinesin-1 in a one-to-one mechanical competition. A large force output of DDB is consistent with high minus-end-directed forces exerted on lipid droplets in Drosophila embryos 35 and single phagosomes inside mouse macrophage cells 14 . Furthermore, formation of strong DDB complexes bypasses the previously postulated requirement for a highly ordered spatial organization of dyneins on the surface of cellular cargos. It remains to be seen how diverse cargo adaptor proteins other than BICD2 affect the force production of the dynein-dynactin complex and regulate dynein's activity throughout the cell.
Previous in vivo optical trapping recordings have detected periodic peaks spaced at 1-2 pN intervals in the force distributions of dyneindriven cargos. It has been proposed that the peak periodicity represents the force production of single 35 or a pair 14 of dynein motors, and that the larger collective forces originate from multiple (up to 12) dyneins simultaneously engaging with the microtubule to transport the cargo. This model relies on the assumption that the measured peak forces in the retrograde direction represent the maximal force production of a single motor multiplied by the motor copy number 36 . Our results are not fully consistent with this simple mechanical model, because the stall force of single DDB complexes (4.3 pN) is significantly higher than the peak periodicity of these force distributions. We propose that the wide range of cargo stall forces measured during multiple-motor transport in vivo can be affected by the modulation of kinesin and dynein activity by cargo adaptor proteins 37 , premature release of the motors from the microtubule before they come to a complete stall, and nonlinear mechanical coupling between multiple motors engaged with the cargo transport 38 . These possibilities remain to be rigorously tested by characterizing the force production of cargos containing predetermined numbers of motors and their regulators in vitro, such as the artificial cargos employed in this study.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of this paper.
Note: Supplementary Information is available in the online version of the paper Protein expression and purification. Human dynein and BICD2N expression and purification using the baculovirus insect cell system was performed as described previously 3 . Briefly, constructs for either the full dynein complex or BICD2N were integrated into the EMBac or EMBacY baculovirus genome and p2 baculovirus was produced. For protein expression, a 500 ml Sf9 cell suspension was infected with 5 ml p2 baculovirus and incubated at 27 • C while shaking at 124 r.p.m. for 70-75 h. A ∼2.5 g cell pellet was lysed using a tissue homogenizer (Wheaton), cleared by centrifugation and incubated with 2 to 5 ml IgG Sepharose 6 Fast Flow (GE Healthcare). The protein was removed from the beads with TEV protease and purified by size-exclusion chromatography using either a G4000SW XL column (TOSOH Bioscience) or a Superose 6 column (GE Healthcare) on an Ettan LC system (GE Healthcare). The appropriate fractions were concentrated, snap frozen in liquid nitrogen and stored at −80 • C. Dynactin was purified from pig brain using the largescale SP-Sepharose purification protocol 5 . Protein size and purity were confirmed by SDS-PAGE using Novex 4-12% Bis-Tris precast gels using either MOPS or MES buffer (Life Technologies) and stained with Instant Blue ( Supplementary  Fig. 5 ). Protein concentration was measured using the Quick Start Bradford kit (Bio-Rad).
Full-length yeast cytoplasmic dynein tagged with GFP at the N-terminal tail and with DHA (Promega) at the C terminus (GFP-Dyn 471kD -DHA) 39 was expressed and purified as described previously 28 . Briefly, frozen yeast pellets were ground in a commercial steel coffee grinder and the resulting powder was thawed in lysis buffer (150 mM HEPES, 250 mM K acetate, 10 mM Mg acetate, 5 mM EGTA, 5 mM phenylmethylsulfonyl fluoride, 500 mM MgATP, 50% glycerol, pH 7.4). Following centrifugation at 270,000g for 45 min, the supernatant was incubated with IgG Sepharose beads (GE Healthcare Life Sciences, 17-0969-01) at 4 • C for 1 h. The beads were washed twice and transferred into TEV protease buffer (150 mM KCl, 10 mM Tris-HCl, 10% glycerol, 1 mM TCEP, 1 mM phenylmethylsulfonyl fluoride, 100 mM ATP, pH 8.0). Dynein was cleaved from the beads by incubation with TEV protease at 16 • C for 1 h.
Axonemes were extracted from live sea urchins. Tubulin used for the assembly of microtubules was purified from fresh pig brains through two polymerizationdepolymerization cycles in a high-molarity buffer 40 . To assemble microtubules for motility experiments, tubulin was polymerized in the presence of 20 µM taxol in BRB80 buffer at 37 • C for 30 min and remaining free tubulin dimers were removed by centrifugation.
Functionalization of complementary DNA oligonucleotides.
Two complementary amine-modified 74 bp oligonucleotides (IDT) with the sequences /5AmMC12/5 -T GGTCAATACTAGGAGCAGAGATGGCAGGAGTCAGATGAACAGATAGTG GAGGCAGGGTCAGCGCGAGATCGTC-3 (Strand 1) and /5AmMC12/5 ATGA CGATCTCGCGCTGACCCTGCCTCCACTATCTGTTCATCTGACTCCTGCCA TCTCTGCTCCTAGTATTGAC-3 (Strand 2) were designed to minimize potential secondary structures and contain a 2-nucleotide overhang on each end, followed by a 12-carbon spacer terminating with an amine group. Strands 1 and 2 (25 µM) were separately labelled with 1.25 mM BG-GLA N -hydroxysuccinimide (NHS) (New England BioLabs, S9151S) and 1 mM alkyl chloride (AC) NHS (Promega, P6751), respectively, in a 50 mM HEPES pH 8.5 buffer containing 50% v/v dimethylsulfoxide. The reaction was allowed to proceed for 30 min at room temperature, after which the DNA was de-salted and exchanged into dynein motility buffer (DMB: 30 mM HEPES, 5 mM MgSO 4 , 1 mM EGTA, pH 7.0 with KOH) through five consecutive spins through 3,000 MWCO spin filters. DNA labelling was confirmed by gel electrophoresis using a 15% TBE-Urea gel, and the DNA concentration and purity were assessed by measuring A 230 nm , A 260 nm , and A 280 nm absorbances.
Labelling dynein and kinesin with DNA oligonucleotides. SNAPf-dynein was mixed with BG-GLA-Strand 1 and kinesin-HaloTag was mixed with AC-Strand 2 for 1 h at 4 • C. After the reaction, 10-fold molar excess of dye (BG-GLA-Alexa647 for dynein or AC-TMR for kinesin) was added to the reaction mixture for 15 min at 4 • C to label remaining sites that were not labelled by DNA. The DNA labelling efficiency was highly sensitive to DNA and protein concentrations. In the case of kinesin, labelling efficiency was calculated by comparing the intensities of the labelled and unlabelled bands that were clearly separated on the 4-12% Bis-Tris SDS-PAGE gel (Fig. 4b) . For dynein, the labelled and unlabelled bands were virtually indistinguishable on the gel due to its high molecular weight. In this case, the labelling efficiency was estimated by running a band of dynein almost fully labelled with DNA that shows no Alexa647 fluorescence and a band of DNA-free dynein that is strongly fluorescent. The labelling efficiencies of the unknown dynein samples were estimated by comparing the relative Alexa647 fluorescence intensity of the band with that of ∼100%-labelled and 0%-labelled control bands (Fig. 4c ). The DNA labelling ratio was optimized to yield a ∼30% efficiency for both dynein and kinesin to minimize the likelihood of a single dimeric motor being labelled with two DNA strands to a <9%. Excess DNA and fluorophores were removed from both motors via microtubule bind and release (MTBR).
MTBR purification of human dynein. Human dynein was purified and separated from DNA and Alexa647 using a modification of the MTBR protocol previously established for yeast dynein 28 . First, ∼200 nM dynein was mixed with 2 mg ml −1 microtubules and allowed to bind at room temperature for 10 min (typical reaction volume was ∼300 µl). Then, the dynein/microtubule mixture was centrifuged through 200 µl of sucrose cushion (25% sucrose and 100 µM taxol in DMB buffer: 30 mM HEPES, 5 mM MgSO 4 , 1 mM EGTA, pH 7.0 with KOH) for 10 min at 22 • C and 40,000 r.p.m. in a TLA 120.1 rotor (Beckman Coulter). The pellet was washed twice with DMB supplemented with 100 µM taxol and 1 mM dithiothreitol (DTT), then resuspended in half of dynein's original volume of release buffer (DMB supplemented with 150 mM KCl, 2 mM ATP and 1 mM DTT) and allowed to release at room temperature for 10 min. The solution was then centrifuged for 10 min at 22 • C and 40,000 r.p.m. to remove microtubules from free dynein. The supernatant was supplemented with 20% v/w glycerol and stored at −80 • C.
Coating beads and quantum dots with anti-GFP antibodies. Carboxyl latex beads (Life Technologies), 860 nm and 200 nm in diameter, were coated with custommade rabbit polyclonal anti-GFP antibodies (Covance) with EDC and sulfo-NHS crosslinking (Pierce). One hundred microlitres of 4% v/w bead stock was mixed with ∼1 mg of antibody in coupling buffer (100 mM sodium phosphate buffer, pH 7.4) and reacted with shaking at room temperature for 30 min. The labelled beads were then passivated by adding 10 mg ml −1 BSA and stored in 1× PBS (phosphatebuffered saline, pH 7.4) supplemented with 0.1% sodium azide and 0.5 mg ml −1 BSA at 4 • C.
Amine-coated quantum dots emitting at 585 nm (QD585; Invitrogen) were labelled with the same rabbit polyclonal anti-GFP antibodies (Covance) via sulfo-SMCC crosslinking (Pierce). QD585 were dissolved in 100 mM pH 8.0 borate buffer to a 200 nM final concentration and incubated with a 250-fold excess of sulfo-SMCC for 1 h. Excess crosslinker was removed by two runs through a 30,000 MWCO spin filter and QD585 were transferred into dynein motility buffer (DMB: 30 mM HEPES, 5 mM MgSO 4 , 1 mM EGTA, pH 7.0 with KOH). Antibodies were reduced with 2 mM DTT for 30 min and residual DTT was removed by three runs through 7,000 MWCO spin de-salting columns. Activated QD585s were then incubated with a fourfold molar excess of the reduced antibodies for 1 h. The reaction was quenched with the addition of 20 mM Tris pH 8.0 and spin-concentrated to obtain the desired final concentration.
Optical trap assay. Dynein concentration was determined for each batch of protein.
The protein was diluted until less than 30% of beads exhibited any activity when brought in contact with an axoneme, ensuring that >95% of observed events can be attributed to the actions of single motors. When BICD2N and/or dynactin were added to the assay, they were mixed with dynein at 1:5:2 molar ratio (dynein/dynactin/BICD2N) and incubated at 4 • C for 5 min before adding the complex to beads. Dynein with any auxiliary proteins was then allowed to bind to 860-nm-diameter latex beads for 10 min at 4 • C before proceeding with sample preparation. The sample chamber was loaded by first flowing Cy5-labelled axonemes in dynein motility buffer (DMB: 30 mM HEPES, 5 mM MgSO 4 , 1 mM EGTA, pH 7.0 with KOH), followed by a solution of dynein-or DDB-coated beads in motility/imaging buffer (DMB supplemented with 35 µg ml −1 PCD, 2.5 mM PCA, 10 mM DTT, 1 mg ml −1 casein and 2 mM ATP).
All trapping experiments were performed on a custom-built optical trap microscope, as described previously 28 . Cy5-labelled axonemes were brought to the centre of the field of view with a piezo-driven servo XY stage (M-687, Physik Instrumente). Beads were trapped with a focused 1,064 nm beam using a 100× 1.49 DOI: 10.1038/ncb3393 N.A. apochromat oil-immersion objective (Nikon). The trap was steered with a pair of perpendicular acousto-optical deflectors (AA Opto-Electronic) and lowered to the surface of the axoneme by moving the trapping objective with a piezo flexure objective scanner (P-721 PIFOC, Physik Instrumente). The position of the bead relative to the centre of the trap was monitored by imaging the back-focal plane of a 1.4 N.A. oil-immersion condenser (Nikon) onto a position-sensitive detector (First Sensor). Signals were acquired at either 20 kHz or 5 kHz, and position feedback was performed at up to 200 Hz. Detector response was calibrated by rapidly rasterscanning the laser across a trapped bead and trap stiffness was obtained from the Lorentzian fit to the power spectrum of a trapped bead. Typical stiffness values used in these assays ranged from 0.008 pN nm −1 to 0.06 pN nm −1 . Trap stiffness is adjusted to allow motors to travel 100 nm on average before stalling.
Motility and photobleaching assays. Single-molecule motility assays were carried out on a custom-built objective-type TIRF set-up, built around the body of a commercial Nikon Ti-E microscope. Fluorophores were visualized with a 100× 1.49 N.A. apochromat oil-immersion objective (Nikon) and imaged onto an electronmultiplying CCD (charge-coupled device) camera (Andor). Assay preparation was identical to the optical trap sample preparation described in a previous section, except without the addition of latex beads. In the dynein-kinesin crosslinking motility experiments, dynein-DNA and kinesin-DNA were allowed to react with each other for 10 min at 4 • C before being diluted to the final desired concentration. Photobleaching experiments were performed without the addition of ATP to ensure that motors remain stationary on axonemes. More than 95% of spots bleached completely over the course of a 200-frame video.
For dynein-driven bead motility experiments, 200 nm latex beads coated with GFP antibodies were sparsely decorated with dynein (with or without dynactin and BICD2N) and imaged with either bright-field illumination or scattered-light fluorescence. To ensure single-molecule conditions, the concentration of dynein was reduced until >90% of beads did not visibly interact with axonemes following contact. The trap was used to measure the velocity of individual dynein motors carrying 860-nm-diameter beads, because these beads are too large to encounter microtubules with sufficient frequency by diffusion alone.
The dynein-kinesin co-localization motility experiments were performed on microtubules. We observed that using axonemes versus microtubules had a modest effect on dynein recruitment to the tracks and initiation of motility, but not on its velocity or processivity following recruitment. Microtubules were used for the co-localization experiments mainly to obtain longer tracks for processive motility. For surface immobilization of microtubules, 1% of biotinylated tubulin was incorporated into the microtubule polymerization reaction. Biotinylated microtubules were attached to the coverslips pre-coated with streptavidin and BSAbiotin. Following microtubule attachment, coverslips were passivated for 5 min by incubation in DMB supplemented with 1 mg ml −1 casein.
